Autopsy report · NCT00775164

Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study

“Inadequate enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of Minnesota

Sponsor type

University, hospital or other

Conditions

Obesity; Insulin Resistance

Interventions

pioglitazone; Metformin

Participants

0

Trials that died the same way

• Prophylactic Phenobarbital After Neonatal Seizures
  “Inadequate rate of enrollment” (92% match in meaning)
• Unpinning Termination Therapy for VT/VF
  “Lack of enrollment” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.